Insulin-like growth factor-1 provides protection against psychosine-induced apoptosis in cultured mouse oligodendrocyte progenitor cells using primarily the PI3K/Akt pathway

Molecular and Cellular Neuroscience

Volumn 30, Issue 3, 2005, Pages 398-407

  Zaka, Mariam ^a   Rafi, Mohammad A ^a   Rao, Han Zhi ^a   Luzi, Paola ^a   Wenger, David A ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN KINASE B; PSYCHOSINE; SOMATOMEDIN C;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; DEMYELINATION; ENZYME ACTIVATION; MOUSE; NONHUMAN; OLIGODENDROGLIA; PHOSPHORYLATION; PRIORITY JOURNAL; STEM CELL;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; APOPTOSIS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; INSULIN-LIKE GROWTH FACTOR I; LEUKODYSTROPHY, GLOBOID CELL; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED C57BL; OLIGODENDROGLIA; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; PSYCHOSINE; RECEPTOR, IGF TYPE 1; STEM CELLS;

ANIMALIA;

EID: 26244449076     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcn.2005.08.004     Document Type: Article

References (70)

1. B.A. Barres, I.K. Hart, H.S. Coles, J.F. Burne, J.T. Voyvodic, W.D. Richardson, and M.C. Raff Cell death and control of cell survival in the oligodendrocyte lineage Cell 70 1992 31 46
2. B.A. Barres, R. Schmid, M. Sendnter, and M.C. Raff Multiple extracellular signals are required for long-term oligodendrocyte survival Development 188 1993 283 295
3. R. Baserga The contradictions of the insulin-like growth factor 1 receptor Oncogene 19 2000 5574 5581
4. R. Baserga, A. Hongo, M. Rubini, M. Prisco, and B. Valentinis The IGF-1 receptor in cell growth, transformation and apoptosis Biochim. Biophys. Acta 1332 1997 105 126
5. G. Blum, A. Gazit, and A. Levitzki Substrate competitive inhibitors of IGF-1 receptor kinase Biochemistry 39 2000 15705 15712
6. G. Blum, A. Gazit, and A. Levitzki Development of new insulin-like growth factor-1 receptor kinase inhibitors using catechol mimics J. Biol. Chem. 278 2003 40442 40454
7. W.M. Campana, S.J. Darin, and J.S. O'Brien Phosphatidyl 3-kinase and Akt protein kinase mediate IGF-I- and prosaptide-induced survival in Schwann cells J. Neurosci. Res. 57 1999 332 341
8. K.H. Cho, M.W. Kim, and S.U. Kim Tissue culture model of Krabbe's disease: psychosine cytotoxicity in rat oligodendrocyte cultures Dev. Neurosci. 19 1997 321 327
9. Q.L. Cui, W.H. Zheng, R. Quirion, and G. Almazan Inhibition of Src-like kinases reveals Akt-dependent and -independent pathways in insulin-like growth factor-1-mediated oligodendrocyte progenitor survival J. Biol. Chem. 280 2005 8918 8928
10. S.R. Datta, A. Brunet, and M.E. Greenberg Cellular survival: a play in three Akts Genes Dev. 13 1999 2905 2927
11. M. Dubois-Dalcq, and K. Murray Why are growth factors important in oligodendrocyte physiology Pathol. Biol. 48 2000 80 86
12. H. Dudek, S.R. Datta, T.F. Franke, M.J. Birnbaum, R. Yao, G.M. Cooper, R.A. Segal, D.R. Kaplan, and M.E. Greenber Regulation of neuronal survival by the serine-threonine protein kinase Akt Science 275 1997 661 665
13. J. Dupont, and D. Le Roith Insulin-like growth factor 1 and oestradiol promote cell proliferation of MCF-7 breast cancer cells: new insights into their synergistic effects J. Clin. Pathol. Mol. Pathol. 54 2001 149 154
14. S. Ebner, M. Dunbar, and R.D. McKinnon Distinct roles for PI3K in proliferation and survival of oligodendrocyte progenitor cells J. Neurosci. Res. 62 2000 336 345
15. M.L. Escolar, M.D. Poe, J.M. Provenzale, K.C. Richards, J. Allison, S. Wood, D.A. Wenger, D. Pietryga, D. Wall, M. Champagne, R. Morse, W. Krivit, and J. Kurtzberg Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease N. Engl. J. Med. 352 2005 2069 2081
16. A. Flores, B.S. Mallon, T. Matsui, B.S. Mallon, T. Matsui, W. Ogawa, A. Rosenzweig, T. Okamoto, and W.B. Macklin Akt-mediated survival of oligodendrocytes induced by neuregulin J. Neurosci. 20 2000 7622 7630
17. Y.A. Hannun, and R.M. Bell Lysosphingolipids inhibit protein kinase C: implication for the sphingolipidoses Science 235 1987 670 674
18. E. Haq, S. Giri, I. Singh, and A.K. Singh Molecular mechanism of psychosine-induced cell death in human oligodendrocyte cell line J. Neurochem. 86 2003 1428 1440
19. I. Hideki, and K. Suzuki Progressive accumulation of toxic metabolite in a genetic leukodystrophy Science 224 1984 753 755
20. J. Hsieh, J.B. Aimone, B.K. Kasper, T. Kuwabara, K. Nakashima, and F.H. Gage IGF-1 instructs multipotent adult neural progenitor cells to become oligodendrocytes J. Cell Biol. 164 2004 111 122
21. M. Jatana, S. Giri, and A.K. Singh Apoptotic positive cells in Krabbe brain and induction of apoptosis in rat C6 glial cells by psychosine Neurosci. Lett. 330 2002 183 187
22. S. Komoly, L.D. Hudson, H.D. Webster, and C.A. Bondy Insulin-like growth factor 1 gene expression is induced in astrocytes during experimental demyelination Proc. Natl. Acad. Sci. U. S. A. 89 1992 1894 1898
23. G. Kulik, and M.J. Weber Akt-dependent and -independent survival signaling pathways utilized by insulin-like growth factor I Mol. Cell. Biol. 18 1998 6711 6718
24. G. Kulik, A. Klippel, and M.J. Weber Antiapoptotic signaling by the insulin-like growth factor 1 receptor, phosphatidylinositol 3-kinase, and Akt Mol. Cell. Biol. 17 1997 1595 1606
25. W. Krivit, J.H. Sung, E.G. Shapiro, and L.A. Lockman Microglia: the effector cell for reconstitution of the central nervous system following bone marrow transplantation for lysosomal and peroxisomal storage diseases Cell Transplant 4 1995 385 392
26. S. LeVine, and M.A. Brown IL-6 and TNF-α expression of twitcher, quaking and normal mice J. Neuroimmunol. 73 1997 47 56
27. Q. Liu, W. Ning, R. Dantzer, G.G. Freund, and K.W. Kelley Activation of protein kinase C-zeta and phosphatidylinositol 3′-kinase and promotion of macrophage differentiation by insulin-like growth factor-I J. Immunol. 160 1998 1393 1401
28. O.H. Lowry, N.J. Rosebrough, A.L. Farr, and R.J. Randall Protein measurement with the Folin phenol reagent J. Biol. Chem. 193 1951 265 275
29. A. Luddi, M. Volterrani, M. Strazza, A. Smorlesi, M.A. Rafi, J. Datto, D.A. Wenger, and E. Constantino-Ceccarini Retrovirus-mediated gene transfer and galactocerebrosidase uptake into twitcher glial cells results in appropriate localization and phenotype correction Neurobiology 8 2001 600 610
30. S.M. Maira, I. Galetic, D.P. Brazil, S. Kaech, E. Ingley, M. Thelen, and B. Hemmings Carboxyl-terminal modulator protein (CTMP), a negative regulator of PKB/Akt and v-Akt at the plasma membrane Science 294 2001 374 380
31. J.L. Mason, J. Jones, M. Taniike, M. Morell, K. Suzuki, and G. Matsushima Mature oligodendrocyte apoptosis precedes IGF-1 production and oligodendrocyte progenitor accumulation and differentiation during demyelination/remyelination J. Neurosci. Res. 61 2000 251 262
32. J.L. Mason, P. Ye, K. Suzuki, A.J. D'Ercole, and G. Matsushima Insulin-like growth factor-1 inhibits mature oligodendrocyte apoptosis during primary demyelination J. Neurosci. 20 2000 5703 5709
33. J.L. Mason, S. Xuan, J. Dragatsis, A. Efstratiadis, and J.E. Goldman Insulin-like growth factor (IGF) signaling through type 1 IGF receptor plays an important role in remyelination J. Neurosci. 23 2003 7710 7718
34. K. Mitsuo, T. Kobayashi, N. Shinnoh, and I. Goto Biosynthesis of galactosylsphingosine (psychosine) in the twitcher mouse J. Chem. Res. 14 1989 899 903
35. T. Miyatake, and K. Suzuki Globoid cell leukodystrophy: additional deficiency of psychosine galactosidase Biochem. Biophys. Res. Commun. 48 1972 538 543
36. R.L. Mozell, and F.A. McMorris Insulin-like growth factor I stimulates regeneration of oligodendrocytes in vitro Ann. N. Y. Acad. Sci. 540 1988 430 432
37. S6K signaling during insulin, insulin-like growth factor-1, and interleukin-4 stimulation J. Biol. Chem. 269 1993 28783 28789
38. J.K. Ness, and T.L. Wood Insulin-like growth factor I, but not neurotrophin-3, sustains Akt activation and provides long-term protection of immature oligodendrocytes from glutamate-mediated apoptosis Mol. Cell. Neurosci. 20 2002 476 488
39. M. Parrizas, A.R. Saltiel, and D. LeRoith Insulin-like growth factor I inhibits apoptosis using the phosphatidylinositol 3′-kinase and mitogen-activated protein kinase pathways J. Biol. Chem. 272 1997 154 161
40. F. Peruzzi, M. Prisco, M. Dews, P. Salomoni, E. Grassilli, G. Romano, B. Calabretta, and R. Baserga Multiple signaling pathways of the insulin-like growth factor-1 receptor in protection from apoptosis Mol. Cell. Biol. 19 1999 7203 7215
41. M. Prisco, G. Romano, F. Peruzzi, and R. Baserga Insulin and IGF-1 receptors signaling in protection from apoptosis Horm. Metab. Res. 31 1999 80 89
42. E.E. Rodgers, and A.B. Theibert Functions of PI3-kinase in development of the nervous system Int. J. Dev. Neurosci. 20 2002 187 197
43. C. Sakakura, Y. Igarashi, and J.K. Anand Plasmalopsychosine of human brain mimics the effects of nerve growth factor by activating its receptor kinase and mitogen-activated protein kinase in PC12 cells J. Biol. Chem. 271 1996 946 952
44. R. Seger, and E.G. Krebs The MAPK signaling cascade FASEB J. 9 1995 726 735
45. C. Sell, R. Baserga, and R. Rubin Insulin-like growth factor-I (IGF-I) and the IGF-I receptor prevent etoposide-induced apoptosis Cancer Res. 55 1995 303 306
46. Y. Shan, T.-L. Yang, R. Mestril, and P.H. Wang Hsp10 and Hsp60 suppress ubiquitination of insulin-like growth factor-1 receptor and augment insulin-like growth factor-1 receptor signaling in cardiac muscle J. Biol. Chem. 278 2003 45492 45498
47. R.J. Singleton, V. Dixit, and E.L. Feldman Type I insulin-like growth factor receptor activation regulates apoptotic proteins J. Biol. Chem. 271 1996 31791 31794
48. V. Stambolic, A. Suzuki, J.L. de la Pompa, G.M. Brothers, C. Mirtsos, T. Sasaki, J. Ruland, J.M. Penninger, D.P. Siderovski, and T.W. Mak Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN Cell 95 1998 29 39
49. N. Sueyoshi, T. Maehara, and M. Ito Apoptosis of Neuro2a cells induced by lysosphingolipids with naturally occurring stereochemical configuration J. Lipid Res. 42 2001 1197 1202
50. S. Sugama, S.U. Kim, H. Ida, and Y. Eto Psychosine cytotoxicity in rat neural cell cultures and protection by phorbol ester and dimethyl sulfoxide Pediat. Res. 28 1990 473 476
51. K. Suzuki Twenty five years of the "Psychosine Hypothesis": a personal perspective of its history and present status Neurochem. Res. 23 1998 251 259
52. K. Suzuki, and Y. Suzuki Globoid cell leukodystrophy (Krabbe's disease): deficiency of galactocerebroside β-galactosidase Proc. Natl. Acad. Sci. U. S. A. 66 1970 302 309
53. K. Suzuki, and K. Suzuki The twitcher mouse: a model for Krabbe disease and for experimental therapies Brain Pathol. 5 1995 249 258
54. L. Svennerholm, M.-T. Vanier, and J.E. Mansson Krabbe disease: a galactosylsphingosine (psychosine) lipidosis J. Lipid Res. 21 1980 53 58
55. K. Tanaka, and H.D. Webster Effects of psychosine (galactosylsphingosine) on the survival and the fine structure of cultured Schwann cells J. Neuropathol. Exp. Neurol. 52 1993 490 498
56. M. Taniike, I. Mohri, N. Eguchi, D. Irikura, Y. Urade, S. Okada, and K. Suzuki An apoptotic depletion of oligodendrocytes in the twitcher, a murine model of globoid cell leukodystrophy J. Neuropathol. Exp. Neurol. 58 1999 644 653
57. J. Tohyama, J. Matsuda, and K. Suzuki Psychosine as potent an inducer of cell death as C6-Ceramide in cultured fibroblasts and in MOCH-1 cells Neurochem. Res. 26 2001 667 671
58. M. Vanier, and L. Svennerholm Chemical pathway of Krabbe disease: the occurrence of psychosine and other neural sphingoglycolipids Adv. Exp. Med. Biol. 68 1976 115 126
59. G.S. Vemuri, and A.F. McMorris Oligodendrocytes and their precursors require phosphatidylinositol 3-kinase signaling for survival Dev. 122 1996 2529 2537
60. Y. Wang, M. Malkowski, J. Hailey, T. Turek-Etienne, T. Tripodi, and J.A. Pachter Screening for small molecule inhibitors of insulin-like growth factor-1 receptor (IGF-1R) kinase: comparison of homogeneous time-resolved fluorescence and 33P-ATP plate assay formats J. Exp. Ther. Oncol. 4 2004 111 119
61. D.A. Wenger, K. Suzuki, Y. Suzuki, and K. Suzuki Galactosylceramide lipidosis. Globoid cell leukodystrophy (Krabbe disease) C.R. Scriver A.L. Beaudet D. Valle W.S. Sly The Metabolic and Molecular Bases of Inherited Disease 8th ed. 2001 McGraw-Hill New York 3669 3694
62. J.R. Woodgett, J. Avruch, and J. Kyriakis The stress activated protein kinase pathway Cancer Surv. 27 1996 127 138
63. Z. Xia, M. Dickens, J. Raingeaud, R.J. Davis, R.J. Davis, and M.E. Greenberg Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis Science 270 1995 1326 1331
64. D.L. Yao, W. Liu, L.D. Hudson, and H.D. Webster Insulin-like growth factor treatment reduces demyelination and up-regulates gene expression of myelin-related proteins in experimental autoimmune encephalomyelitis Proc. Natl. Acad. Sci. U. S. A. 13 1995 6190 6194
65. P. Ye, K.H. Lee, and A.J. D'Ercole Insulin-like growth factor-I (IGF-I) protects myelination from undernutritional insult: studies of transgenic mice overexpressing IGF-I in brain J. Neurosci. Res. 62 2000 700 708
66. P. Ye, L. Li, R.G. Richards, R.P. DiAugustine, and A.J. D'Ercole Myelination is altered in insulin-like growth factor-1 null mutant mice J. Neurosci. 22 2002 6041 6051
67. C. Yu, M. Takeda, and B. Soliven Regulation of cell cycle proteins by TNF-alpha and TGF-beta in cells of oligodendroglial lineage J. Neuroimmunol. 108 2000 2 10
68. M. Zaka, and D.A. Wenger Psychosine-induced apoptosis in a mouse oligodendrocyte progenitor cell line is mediated by caspase activation Neurosci. Lett. 358 2004 205 209
69. W.H. Zheng, S. Kar, S. Dore, and R. Quirion Insulin-like growth factor-I (IGF-I): a neuroprotective trophic factor acting via the Akt kinase pathway J. Transm., Suppl. 60 2000 261 272
70. W. Zumkeller The effect of insulin-like growth factors on brain myelination and their potential therapeutic application in myelination disorders Eur. J. Paediatr. Neurol. 4 1997 91 101